FUSTIBAL

Fustibal is a biotechnology startup that develops antibody-based nanomedicines for multi-targeted cancer therapy. Its oncology therapeutics functionalize the tumor-targeting capability of antibodies with the large drug payload and the prolonged circulation time of nanomedicines for synergistic therapeutic effects. Through data-based computational platforms and modular drug design, we repurpose and improve existing chemical and biological pharmaceuticals for efficacy, safety, and unmet medical needs.